In Brief: NMC's Hampers
This article was originally published in The Gray Sheet
Executive Summary
NMC's Hampers: National Medical Care Chairman, President and CEO Constantine Hampers resigns from his position at the dialysis device company, as well as his posts of director and executive VP for NMC parent W.R. Grace. Hampers, who founded NMC in 1968, will remain as an advisor to the company "on certain international business development opportunities," according to a Grace release. An "executive committee" of NMC and Grace managers will oversee operations at NMC until completion of the firm's acquisition by German dialysis firm Fresenius AG. The $2.3 bil. deal, for which a definitive agreement was signed in early February ("The Gray Sheet" Feb. 12, p. 8), is expected to close in August...
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.